Beyond Air, Inc. income statement
In fiscal 2026, Beyond Air, Inc. reported revenue of $7.7m, up 107.3% on the year before, operating income of −$29.0m (a -378.2% margin) and net income of −$33.2m, or −$4.01 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2019Mar 2019 | 2020Mar 2020 | 2021Mar 2021 | 2024Mar 2024 | 2025Mar 2025 | 2026Mar 2026 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|
| Revenue | 8 | 1 | 1 | 1 | 4 | 8 | 8 |
| Cost of revenue | — | — | — | 2 | 5 | 7 | 7 |
| Gross profit | — | — | — | −1 | −2 | 0 | 0 |
| Research and development | 4 | 11 | 13 | 24 | 17 | 10 | 9 |
| Selling, general and administrative | — | — | — | 37 | 26 | 19 | 19 |
| General and administrative | 7 | 9 | 10 | — | — | — | — |
| Operating income | −3 | −18 | −22 | −63 | −45 | −29 | −28 |
| Interest expense | 0 | 0 | 1 | 3 | 3 | 4 | 4 |
| Income before tax | −7 | −20 | −23 | −64 | −48 | −34 | −34 |
| Income tax | — | −0 | — | — | — | — | — |
| Net income | −7 | −20 | −23 | −60 | −47 | −33 | −33 |
| Diluted EPS | −$7.70 | −$0.89 | −$12.70 | −$0.91 | −$13.77 | −$4.01 | — |
| Diluted shares (average) | — | 1m | 2m | 3m | 3m | 8m | — |
| EBITDA | −3 | −18 | −22 | −61 | −42 | −26 | −25 |
| Quarter | 2025 Q2Sept 2024 | 2025 Q3Dec 2024 | 2025 Q4Mar 2025 | 2026 Q1Jun 2025 | 2026 Q2Sept 2025 | 2026 Q3Dec 2025 | 2026 Q4Mar 2026 | 2027 Q1Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 |
| Cost of revenue | 2 | 1 | 1 | 2 | 2 | 2 | 2 | 2 |
| Gross profit | −1 | −0 | −0 | 0 | −0 | 0 | 0 | 0 |
| Research and development | 5 | 3 | 3 | 3 | 2 | 2 | 2 | 2 |
| Selling, general and administrative | 7 | 8 | 4 | 5 | 5 | 4 | 5 | 5 |
| Operating income | −13 | −11 | −7 | −8 | −8 | −7 | −7 | −7 |
| Interest expense | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Income before tax | −14 | −13 | −8 | −8 | −8 | −8 | −10 | −8 |
| Net income | −13 | −13 | −8 | −8 | −8 | −7 | −10 | −8 |
| Diluted EPS | −$5.67 | −$2.96 | −$1.00 | −$30.67 | −$25.00 | −$17.00 | −$0.57 | −$11.00 |
| EBITDA | −12 | −10 | −6 | −7 | −7 | −6 | −6 | −6 |
Compare with peers
- Invo Fertility, Inc. income statement
- Anbio Biotechnology income statement
- Nuwellis, Inc. income statement
- Milestone Scientific Inc. income statement
- Neuroone Medical Technologies Corp income statement
Head to head: IVF vs XAIRNNNN vs XAIRNUWE vs XAIR
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies